 |
|
A case of thanatophoric dysplasia type I with an R248C mutation in the
Eun Jung Noe (Noe EJ), Han Wook Yoo (Yoo HW), Kwang Nam Kim (Kim KN), So Yeon Lee (Lee SY)
Clin Exp Pediatr. 2010;53(12):1022-1025. Published online 2010 Dec 31 DOI: https://doi.org/10.3345/kjp.2010.53.12.1022
|
|
Citations to this article as recorded by
 Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Hassan Dianat-Moghadam, Ladan Teimoori-Toolabi
Current Drug Targets.2019; 20(8): 852. CrossRef Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months
Jeon Soo-kyeong, Narae Lee, Mi Hye Bae, Young Mi Han, Kyung Hee Park, Shin Yun Byun
Fetal and Pediatric Pathology.2018; 37(5): 363. CrossRef Fibroblast growth factor (FGF) signaling in development and skeletal diseases
Chad M. Teven, Evan M. Farina, Jane Rivas, Russell R. Reid
Genes & Diseases.2014; 1(2): 199. CrossRef Diagnostic anténatal d’un cas de nanisme thanatophore type I
N’goran Kouamé, Anne-Marie N’goan-Domoua, Roger-Daniel N’gbesso, Abdul-Kader Kéita
Imagerie de la Femme.2011; 21(4): 171. CrossRef
|